Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins perform adaptive immune functions in prokaryotic organisms defending against foreign nucleic acids such as viruses. CRISPR/Cas tools have been adapted for use in genome editing and other DNA and RNA targeting applications.
CRISPR/Cas systems are used to target sites of interest within the cell and attach a label such as fluorescence to allow them to be visualized.
Genome editing with CRISPR-Cas9 has been demonstrated in model species such as Arabidopsis, rice and tobacco as well as a few crop species. CRISPR-Cas12a genome editing has also been demonstrated to work in plants. The United States Department of Agriculture (USDA) stated that CRISPR-Cas9 edited crops will not be regulated as GMO.
The following crops have been improved using CRISPR-Cas9 technology:
Genome editing with CRISPR-Cas9 has been demonstrated in model species such as Arabidopsis, rice and tobacco as well as a few crop species. CRISPR-Cas12a genome editing has also been demonstrated to work in plants. The United States Department of Agriculture (USDA) stated that CRISPR-Cas9 edited crops will not be regulated as GMO.
The following crops have been improved using CRISPR-Cas9 technology:
Nucleic acid testing is used to screen and diagnose diseases and conditions. For nucleic acid testing, CRISPR systems are adapted to target nucleic acid sequences that are markers for disease and act as biosensors detecting pathogenic bacteria and viruses.
RAA-CRISPR/Cas12a (recombinase aided amplification assisted CRISPR/Cas12a) was developed to detect E. coli 05157:H7 and was shown to be accurate and sensitive in beef samples spiked with the bacteria.
CAS-EXPAR (CRISPR/Cas9-triggered isothermal exponential amplification reaction) was developed to detect Listeria monocytogenes, a foodborne pathogen found in milk, milk products, eggs, poultry and meat which can cause invasive listeriosis and severe illness in young, elderly and immunocompromised individuals.
CRISPR/Cas13a (APC-Cas) is a system that combines CRISPR with an allosteric probe (AP) that targets whole bacteria (Salmonella enteritidis).
Nucleic acid testing is used to screen and diagnose diseases and conditions. For nucleic acid testing, CRISPR systems are adapted to target nucleic acid sequences that are markers for disease.
RecombineeringRecombineering is a method of genetic engineering in bacterial genomes that involves homologous recombination. In contrast to CRISPR used for gene editing in eukaryotic cells, CRISPR assists the selection of successful recombineering events which change the target sequence and negatively selects cells in which the desired homologous recombination has not occurred. Negative selection occcurs by CRISPR-Cas9 induced double stranded breaks which are lethal in bacteria where non homologous end joining (NHEJ) is not very effective.
CRISPR-Cas systems are being developedcombined with phage therapy to target and degrade DNA of pathogenic bacteria as a selective antimicrobial treatment
CRISPR-Cas3CRISPR-Cas issystems are being developed by Locus Biosciences to target and degrade the DNA of pathogenic bacteria in orderas toa killselective it.antimicrobial treatment
Genome editing with CRISPR-Cas9 has been demonstrated in model species such as Arabidopsis, rice and tobacco as well as a few crop species. CRISPR-Cas12a genome editing has also been demonstrated to work in plants. The United States Department of Agriculture (USDA) stated that CRISPR-Cas9 edited crops will not be regulated as GMO.
Based on the ability of CRISPR systems to sequentially acquire DNA sequences from viral infections, adding them to spacer sequences in a growing array in the CRISPR locus, molecular recorder tools are being developed which can record information provided by researchers or from the cell interactions with the environment.
Genetic screening of mutant libraries is a way to search for genes involved in a desired pathway where mutant genes produce a certain phenotype. CRISPR libraries contain thousands of plasmids with multiple guide RNAs (gRNAs) for each target gene. Cells are treated with the library gRNA and Cas9 creating a population of mutant cells which can be screened for a phenotype of interest. CRISPR libraries can knockout, activate or repress target genes. The following companies and non-profits sell or distribute CRISPR libraries.